DBV Technologies
Priced, Nasdaq: DBVTFrench biotech developing immunotherapy patches that treat food allergies.
Industry: Health Care
First Day Return: +5.8%
DBVT
French biotech developing immunotherapy patches that treat food allergies.
| IPO Date | 10/21/2014 |
|---|---|
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $93 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| IPO Intelligence Only |
| Headquarters | Bagneux, France |
|---|---|
| Founded | 2002 |
| Employees at IPO | 47 |
| Website www.dbv-technologies.com | |
IPO News for DBV Technologies
DBV Technologies (DBVT) Performance
